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Purpose/Objective: In volumetric-modulated arc (VMAT) 
prostate stereotactic body radiotherapy (SBRT), dose 
coverage of the PTV becomes challenging when the sparing of 
the organs at risk (OAR) is strictly pursued. Our current 35Gy-
in-five-fractions prostate SBRT VMAT plans assure PTV33.2Gy 
≥95% only. Looking for an improved PTV33.2Gy, the dosimetric 
impact of a slightly increased near-maximum target dose 
(D2%), and of a prostate-rectum interface spacer were here 
tested. 
Materials and Methods: For eleven patients two CT studies, 
before (NoSpc) or after (Spc) the insertion of SpaceOAR® 
(Augmenix Inc., Waltham, MA) prostate-rectum hydrogel 
spacer, were acquired. On each CT study two VMAT plans, 
Hom-plans (D2% ≤37.5Gy), and Het-plans (D2% ≤40.2Gy), were 
computed. All plans assured D1cc<35Gy for rectum, bladder, 
and urethral-PRV (3mm isotropic expansion), together with 
PTV33.2Gy ≥95%. From the four groups of plans (Hom-NoSpc, 
Hom-Spc, Het-NoSpc, Het-Spc) metrics for target dose 
coverage (D98%, D50%, PTV33.2Gy, PTV35Gy), and rectal dose 
sparing (V18Gy, V28Gy, V32Gy), were then compared by hypothesis 
testing (t-test, Wilcoxon). Linear correlation and ANOVA 
analyses between the variations from spacer insertion in the 
fractional overlap with PTV of the rectum (ΔVrovl), and the 
corresponding variations in PTV33.2Gy, and in rectal VX, were 
also performed. 
Results: According to hypothesis testing, by comparing Spc 
vs. NoSpc plans reductions in rectal V18Gy, V28Gy, and V32Gy, and 
improvements in target D98%, and PTV33.2Gy significantly 
resulted. By comparing Het vs. Hom plans, significant 
improvements in target D50%, PTV33.2Gy, and PTV35Gy, whereas 
no significant reductions in rectal VX, were computed. By 
directly comparing Het-Spc vs. Hom-NoSpc plans, all the 
conceived metrics were significantly improved: PTV33.2Gy, in 
particular, increased from 96.1% (±1.1%) to 98.7% (±1.2%). In 
the Table the mean values (1 sd) of all computed metrics for 
the four types of plans are reported. In the Figure, the mean 
DVHs (± sd) for rectum and PTV when comparing Het-Spc vs. 
Hom-NoSpc plans are shown: the enlargement of the 
therapeutic window is evident. For spacer insertion, ΔVrovl 
significantly correlated with, and was the effective source of 
variation for the observed decrease in rectal V32Gy, and V28Gy. 
By contrast, ΔVrovl neither linearly correlated with, nor was 
the effective source of variation for the observed increase in 
PTV33.2Gy. 
Conclusions: Spacer insertion was causative for 
improvements in rectal dose sparing, but not in target dose 
coverage, whereas increased near maximum dose (D2%) was 
associated with improved target dose coverage. The 
combined use of both spacer insertion and increased D2% 
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Purpose/Objective: To determine tissue electron densities 
using dual energy X-ray computed tomography (DECT) in 
order to improve the accuracy of dose calculations in 
radiotherapy and especially proton therapy treatment 
planning. 
Materials and Methods: A parameterization of the total cross 
section σtot for photon interactions with matter was 
constructed, based on theoretical analysis. From this 
parameterization and measured linear attenuation 
coefficients at a high and low kV setting of the X-ray tube in 
a dual source computed tomography (DSCT) system, the DECT 
method provides effective atomic numbers Z’ and relative 
electron densities ρe’/ρe,w. In this analysis, the spectral 
responses of the DSCT system at both kV settings are used as 
weighting functions. To account for beam hardening in the 
object as present in the CT image we implemented an 
iterative process employing a local energy weighting. The 
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accuracy of this DECT method for determining ρe’/ρe,w has 
been assessed with a 33 cm diameter Gammex 467 tissue 
characterization phantom. The phantom has been scanned on 
a DSCT system (SOMATOM Definition Flash) in DECT spiral 
mode with tube potentials of 80 kV and 140 kV (with 
additional Sn filtration) using a clinical scan protocol. For 
reconstruction of the data a Q30f strength 5 sinogram 
affirmed iterative reconstruction kernel has been used. In 
order to provide high resolution imaging data relevant for 
treatment planning, the data has been reconstructed with a 
slice thickness of 1.0 mm.  
Results: The parameterization of the total cross section σtot 
deviates at most 0.3% from tabulated NIST reference values 
for the elements H to Zn. Relative electron densities ρe’/ρe,w 
have been measured with accuracy better than 1.1% except 
for the inhomogeneous LN-300 insert material (difference of -






Conclusions: From this phantom measurement we conclude 
that the presented DECT method is suitable for accurate 
electron density determination for radiotherapy and in 
particular proton therapy treatment planning. 
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Purpose/Objective: With the application of FFF the criteria 
for QA of non-flattened beams need to be defined. Several 
redefinitions of e.g. flatness, symmetry and field size are 
proposed. However, the validation and usability needs to be 
established in clinical practice. We explored methods for an 
easy evaluation of different beam criteria for water phantom 
data. 
Materials and Methods: Water phantom data are the 
standard input for beam modeling of the TPS and beam QA 
measurements. However, imperfections in water tank data 
often need some pre-processing e.g. noise reduction, 
symmetry error correction and data scaling. Care must be 
taken in conserving the profile shape conservation in the data 
processing. Furthermore, the comparison of measured data 
and stored reference data should be handled in a convenient 
way. We developed an in house tool that meets these two 
constraints and provides the following list of functions: 
1. The resulting relative profiles can be evaluated in terms of 
symmetry and flatness, leading to the baseline objectives.  
2. Reliable field size detection methods (based on derivative 
functions) are available as well as alternative methods for 
field size calculation to handle penumbra regions below the 
50% level (e.g. to comply with methods of the linac 
manufacturer).  
3. Displaying deviations from baseline readily for any shape 
of profile. 
4. A gamma calculation on the profiles as alternative for non-
flat profiles. 
5. Support for the user to discriminate between symmetry 
errors and energy errors. 
6. Normalisation of depth dose curves to the dosimetry 
reference depth, leading to relative depth dose errors based 
on standard dosimetry. 
7. Show depth doses in such a way that they are fully 
compliant with the dosimetry setup of the institute. 
8. Handle multiple datasets for all major water tank vendors 
and selected 2D-scanners. 
9. The tool can be configured for different tasks and 
different users. 
Applied methods and algorithms are documented in detail in 
an extended help file. 
Results: Our tool gives detailed information on deviations 
from baseline, which are not available in software of the 
major vendors. 
